fake semaglutide FDA, Novo Nordisk Warn of Counterfeit Injection Pens Surge in fake #Ozempic #weight-loss

Patients should understand the difference between expected cold sensitivity and symptoms suggesting thyroid dysfunction, anemia, or other metabolic disorders that require investigation and management

Make sure the area is clean to reduce the risk of infection

There is one risk that has nothing to do with the needle

Coverage and accessibility is definitely going to be the biggest challenge as we move forward in treating people with obesity. Benefits beyond weight loss In August, Novo Nordisk, the maker of Ozempic and Wegovy, became the first to demonstrate in a large clinical trial that the drugs provide health benefits beyond weight loss and diabetes management